mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |